All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-33184173

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33184173	A23403G	S	S	COVID-19		View
2	33184173	D614G	S	S	COVID-19		View
3	33184173	C23575T	S	S	COVID-19		View
4	33184173	G25563T	ORF3a	ORF3a	COVID-19		View
5	33184173	Q57H	ORF3a	ORF3a	COVID-19		View
6	33184173	C3037T	NSP3	ORF1a	COVID-19		View
7	33184173	C3730T	NSP3	ORF1a	COVID-19		View
8	33184173	C1059T	NSP2	ORF1a	COVID-19		View
9	33184173	T265I	NSP2	ORF1a	COVID-19		View
10	33184173	C14408T	NSP12	ORF1b	COVID-19		View
11	33184173	P4715L	NSP12	ORF1b	COVID-19		View
12	33184173	G204R	N	N	COVID-19		View
13	33184173	G28881A	N	N	COVID-19		View
14	33184173	G28882A	N	N	COVID-19		View
15	33184173	G28883C	N	N	COVID-19		View
16	33184173	R203K	N	N	COVID-19		View
17	33184173	C241T	5'UTR		COVID-19		View
18	33184173	A17858G			COVID-19		View
19	33184173	C14805T			COVID-19		View
20	33184173	C17747T			COVID-19		View
21	33184173	C8782T			COVID-19		View
22	33184173	G11083T			COVID-19		View
23	33184173	G1397A			COVID-19		View
24	33184173	G26144T			COVID-19		View
25	33184173	T28144C			COVID-19		View
26	33184173	T28688C			COVID-19		View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.